• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Get Smart, Canada: Exploring Smart Pump Implementation, Management, and Compliance with Standards through a Nationwide Survey.《加拿大明智行动:通过全国性调查探索智能输液泵的实施、管理及标准合规情况》
Can J Hosp Pharm. 2023 Jul 5;76(3):185-195. doi: 10.4212/cjhp.3286. eCollection 2023 Summer.
2
Intravenous Smart Pump Drug Library Compliance: A Descriptive Study of 44 Hospitals.静脉智能输液泵药物库合规性:44 家医院的描述性研究。
J Patient Saf. 2018 Dec;14(4):e76-e82. doi: 10.1097/PTS.0000000000000383.
3
Development of a standardized, citywide process for managing smart-pump drug libraries.开发一种用于管理智能泵药物库的标准化全市流程。
Am J Health Syst Pharm. 2018 Jun 15;75(12):893-900. doi: 10.2146/ajhp170262.
4
Critical Care Network in the State of Qatar.卡塔尔国重症监护网络。
Qatar Med J. 2019 Nov 7;2019(2):2. doi: 10.5339/qmj.2019.qccc.2. eCollection 2019.
5
Enterprise standardization and convergence of large-volume infusion pump drug libraries.企业标准化与大容量输液泵药物库的融合。
Am J Health Syst Pharm. 2023 Nov 22;80(23):1743-1751. doi: 10.1093/ajhp/zxad172.
6
Data-based program management of system-wide IV smart pump integration.基于数据的系统范围 IV 智能输液泵集成的程序管理。
Am J Health Syst Pharm. 2024 Jan 1;81(1):e30-e36. doi: 10.1093/ajhp/zxad245.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
Benefits and risks of using smart pumps to reduce medication error rates: a systematic review.使用智能泵降低用药错误率的益处与风险:一项系统综述
Drug Saf. 2014 Dec;37(12):1011-20. doi: 10.1007/s40264-014-0232-1.
9
High-alert medication administration and intravenous smart pumps: A descriptive analysis of clinical practice.高警示药物给药和静脉智能输液泵:临床实践的描述性分析。
Res Social Adm Pharm. 2019 Jul;15(7):889-894. doi: 10.1016/j.sapharm.2019.02.007. Epub 2019 Feb 22.
10
Stakeholder perceptions of smart infusion pumps and drug library updates: A multisite, interdisciplinary study.利益相关者对智能输液泵和药物库更新的看法:一项多地点、跨学科的研究。
Am J Health Syst Pharm. 2019 Sep 1;76(17):1281-1287. doi: 10.1093/ajhp/zxz135.

引用本文的文献

1
N-acetylcysteine for acetaminophen poisoning: translating poison center protocols to the bedside.
CJEM. 2024 Mar;26(3):141-142. doi: 10.1007/s43678-024-00660-0.

本文引用的文献

1
Sentinel Event Alert 63: Optimizing Smart Infusion Pump Safety with DERS.警戒事件通报 63:利用 DERS 优化智能输液泵安全性。
Jt Comm J Qual Patient Saf. 2021 Jun;47(6):394-397. doi: 10.1016/j.jcjq.2021.03.013. Epub 2021 Apr 14.
2
System-Level Patient Safety Practices That Aim to Reduce Medication Errors Associated With Infusion Pumps: An Evidence Review.旨在减少与输液泵相关的用药错误的系统级患者安全实践:证据回顾。
J Patient Saf. 2020 Sep;16(3S Suppl 1):S42-S47. doi: 10.1097/PTS.0000000000000722.
3
Impact of interoperability of smart infusion pumps and an electronic medical record in critical care.智能输液泵与电子病历的互操作性在重症监护中的影响。
Am J Health Syst Pharm. 2020 Jul 23;77(15):1231-1236. doi: 10.1093/ajhp/zxaa164.
4
Stakeholder perceptions of smart infusion pumps and drug library updates: A multisite, interdisciplinary study.利益相关者对智能输液泵和药物库更新的看法:一项多地点、跨学科的研究。
Am J Health Syst Pharm. 2019 Sep 1;76(17):1281-1287. doi: 10.1093/ajhp/zxz135.
5
Unintended Patient Safety Risks Due to Wireless Smart Infusion Pump Library Update Delays.由于无线智能输液泵库更新延迟导致的非预期患者安全风险。
J Patient Saf. 2019 Mar;15(1):e8-e14. doi: 10.1097/PTS.0000000000000562.
6
Clinical and financial effects of smart pump-electronic medical record interoperability at a hospital in a regional health system.区域卫生系统中一家医院智能泵与电子病历互操作性的临床和财务影响。
Am J Health Syst Pharm. 2018 Jul 15;75(14):1064-1068. doi: 10.2146/ajhp161058.
7
A Multi-hospital Before-After Observational Study Using a Point-Prevalence Approach with an Infusion Safety Intervention Bundle to Reduce Intravenous Medication Administration Errors.多医院前后观察性研究采用点患病率方法和输液安全干预包,以减少静脉药物给药错误。
Drug Saf. 2018 Jun;41(6):591-602. doi: 10.1007/s40264-018-0637-3.
8
Accidents and Incidents Related to Intravenous Drug Administration: A Pre-Post Study Following Implementation of Smart Pumps in a Teaching Hospital.与静脉药物给药相关的事故和事件:一家教学医院实施智能输液泵后的前后对照研究。
Drug Saf. 2015 Aug;38(8):729-36. doi: 10.1007/s40264-015-0308-6.
9
Implementation of a smart pump champions program to decrease potential patient harm.实施智能泵倡导计划以减少对患者的潜在伤害。
J Nurs Care Qual. 2015 Apr-Jun;30(2):138-43. doi: 10.1097/NCQ.0000000000000090.
10
Benefits and risks of using smart pumps to reduce medication error rates: a systematic review.使用智能泵降低用药错误率的益处与风险:一项系统综述
Drug Saf. 2014 Dec;37(12):1011-20. doi: 10.1007/s40264-014-0232-1.

《加拿大明智行动:通过全国性调查探索智能输液泵的实施、管理及标准合规情况》

Get Smart, Canada: Exploring Smart Pump Implementation, Management, and Compliance with Standards through a Nationwide Survey.

作者信息

Sproul Ashley, Newman Hillary

机构信息

, BScPharm, PharmD, is with Horizon Health Network, Saint John, New Brunswick.

, BScPharm, BScBio, is with Horizon Health Network, Saint John, New Brunswick.

出版信息

Can J Hosp Pharm. 2023 Jul 5;76(3):185-195. doi: 10.4212/cjhp.3286. eCollection 2023 Summer.

DOI:10.4212/cjhp.3286
PMID:37409144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10284277/
Abstract

BACKGROUND

Smart pump technology is relatively new, and uncertainty exists regarding best practices for development and management of the drug libraries in these devices. In Canadian hospitals, IV smart pumps and their drug libraries are created and maintained according to recommendations from Accreditation Canada and guidelines from the US Institute for Safe Medication Practices (ISMP). Current compliance with these standards in Canada is unknown. However, neither organization provides specific operational steps detailing how to effectively create and manage a drug library, which leaves significant room for interpretation. Furthermore, the human resources dedicated to creation and management of these libraries in accordance with guidelines and standards are unknown.

OBJECTIVES

To describe current compliance with standards and guidelines for smart pump drug libraries; the processes used for drug library set-up, management, training, and support; and the resources currently used for these activities in Canadian hospitals.

METHODS

A 43-question online survey was made available in spring 2021 to multidisciplinary team members involved in implementation of IV smart pumps and/or management of drug libraries in Canadian hospitals.

RESULTS

A total of 55 complete or partial responses were received. Most responses indicated that standards set by Accreditation Canada and ISMP were not being met, with only 30% (14/47) updating their libraries at least quarterly and 47% (20/43) performing quality reviews at least every 6 months. Although the majority of respondents reported regular monitoring of compliance, 30% (11/37) did not perform such monitoring. Results further indicated variation across Canadian hospitals in set-up, management, training, and support related to drug libraries, as well as variation in the human resources available for these activities.

CONCLUSIONS

Canadian health authorities and organizations are not meeting current ISMP and Accreditation Canada standards for smart pumps. Variation exists in terms of strategies for creating and managing drug libraries, as well as in the training and resources needed to support these initiatives. Canadian health authorities and organizations should prioritize meeting these standards and should closely review the resources required to do so.

摘要

背景

智能泵技术相对较新,在这些设备中药物库的开发和管理的最佳实践方面存在不确定性。在加拿大医院,静脉输液智能泵及其药物库是根据加拿大认证协会的建议和美国安全用药实践研究所(ISMP)的指南创建和维护的。目前加拿大对这些标准的遵守情况尚不清楚。然而,这两个组织都没有提供详细说明如何有效创建和管理药物库的具体操作步骤,这留下了很大的解释空间。此外,按照指南和标准专门用于创建和管理这些库的人力资源情况也不清楚。

目的

描述加拿大医院目前对智能泵药物库标准和指南的遵守情况;药物库设置、管理、培训和支持所使用的流程;以及目前用于这些活动的资源。

方法

2021年春季,面向参与加拿大医院静脉输液智能泵实施和/或药物库管理的多学科团队成员开展了一项包含43个问题的在线调查。

结果

共收到55份完整或部分回复。大多数回复表明未达到加拿大认证协会和ISMP制定的标准,只有30%(14/47)至少每季度更新一次药物库,47%(20/43)至少每6个月进行一次质量审查。尽管大多数受访者报告定期监测合规情况,但30%(11/37)未进行此类监测。结果还表明,加拿大各医院在药物库的设置、管理、培训和支持方面存在差异,以及开展这些活动可用的人力资源也存在差异。

结论

加拿大卫生当局和组织未达到当前ISMP和加拿大认证协会关于智能泵的标准。在创建和管理药物库的策略以及支持这些举措所需的培训和资源方面存在差异。加拿大卫生当局和组织应优先满足这些标准,并应密切审查所需资源。